J.P. Marvel Investment Advisors, LLC Charles River Laboratories International, Inc. Transaction History

J.P. Marvel Investment Advisors, LLC

$608 Million
Q3 2024

A detailed history of J.P. Marvel Investment Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, J.P. Marvel Investment Advisors, LLC holds 39,431 shares of CRL stock, worth $7.33 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares

39,431

Previous 39,476 0.11%

Holding current value

$7.33 Million

Previous $8.15 Million 4.75%

% of portfolio

1.28%

Previous 1.34%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$187.96 - $245.29 $8,458 - $11,038	-45 Reduced 0.11%	39,431 $7.77 Million
Q2 2024 Jul 26, 2024	SELL	$206.39 - $268.73 $2,063 - $2,687	-10 Reduced 0.03%	39,476 $8.15 Million
Q1 2024 May 08, 2024	BUY	$203.52 - $273.43 $144,295 - $193,861	709 Added 1.83%	39,486 $10.7 Million
Q4 2023 Feb 13, 2024	SELL	$164.52 - $238.84 $4,113 - $5,971	-25 Reduced 0.06%	38,777 $9.17 Million
Q2 2023 Aug 10, 2023	BUY	$183.71 - $210.25 $437,229 - $500,395	2,380 Added 6.53%	38,802 $8.16 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $19,189 - $25,992	100 Added 0.28%	36,422 $7.35 Million
Q3 2022 Oct 24, 2022	SELL	$182.44 - $250.54 $547 - $751	-3 Reduced 0.01%	36,322 $7.15 Million
Q1 2022 May 12, 2022	BUY	$255.51 - $362.11 $129,543 - $183,589	507 Added 1.42%	36,325 $10.3 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $154,607 - $197,419	440 Added 1.24%	35,818 $13.5 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $29,811 - $36,664	80 Added 0.23%	35,378 $14.6 Million
Q2 2021 Sep 09, 2021	BUY	$294.17 - $371.65 $220,921 - $279,109	751 Added 2.17%	35,298 $13.1 Million
Q1 2021 Sep 09, 2021	BUY	$249.67 - $299.48 $307,843 - $369,258	1,233 Added 3.7%	34,547 $10 Million
Q4 2020 Sep 09, 2021	BUY	$222.0 - $252.62 $23,088 - $26,272	104 Added 0.31%	33,314 $8.32 Million
Q3 2020 Sep 09, 2021	BUY	$175.56 - $226.45 $14,044 - $18,116	80 Added 0.24%	33,210 $7.52 Million
Q2 2020 Sep 09, 2021	BUY	$118.84 - $189.72 $14,260 - $22,766	120 Added 0.36%	33,130 $5.78 Million
Q1 2020 Sep 09, 2021	BUY	$98.9 - $178.34 $137,471 - $247,892	1,390 Added 4.4%	33,010 $4.17 Million
Q3 2019 Nov 20, 2019	BUY	$125.07 - $143.67 $320,179 - $367,795	2,560 Added 8.81%	31,620 $4.19 Million
Q1 2019 May 16, 2019	BUY	$104.82 - $146.73 $786,150 - $1.1 Million	7,500 Added 34.79%	29,060 $4.22 Million
Q4 2018 Feb 13, 2019	BUY	$105.09 - $137.23 $614,776 - $802,795	5,850 Added 37.24%	21,560 $2.44 Million
Q3 2017 Nov 13, 2017	SELL	$96.72 - $109.26 $5,803 - $6,555	-60 Reduced 0.38%	15,710 $1.7 Million
Q2 2017 Aug 24, 2017	BUY	N/A	15,770	15,770 $1.6 Million

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J.P. Marvel Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on J.P. Marvel Investment Advisors, LLC with notifications on news.

Account

J.P. Marvel Investment Advisors, LLC Charles River Laboratories International, Inc. Transaction History